CHC Healthcare Group (TPE:4164)

Market Cap	6.53B -8.9%
Revenue (ttm)	4.21B +4.4%
Net Income	161.42M -50.2%
EPS	0.90 -49.6%
Shares Out	195.31M
PE Ratio	37.22
Forward PE	21.04
Dividend	1.51 (4.51%)
Ex-Dividend Date	Jun 26, 2025

Volume	694,968
Average Volume	970,940
Open	33.00
Previous Close	33.00
Day's Range	32.80 - 33.45
52-Week Range	31.80 - 60.40
Beta	0.21
RSI	37.27
Earnings Date	Mar 12, 2026

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supple...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.